Lecap Asset Management Ltd. Buys Shares of 6,534 Molina Healthcare, Inc. (NYSE:MOH)

Lecap Asset Management Ltd. bought a new position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 6,534 shares of the company's stock, valued at approximately $2,361,000. Molina Healthcare comprises about 0.9% of Lecap Asset Management Ltd.'s holdings, making the stock its 17th biggest position.

A number of other hedge funds have also bought and sold shares of MOH. Vanguard Group Inc. raised its position in Molina Healthcare by 18.4% in the 1st quarter. Vanguard Group Inc. now owns 6,449,375 shares of the company's stock worth $2,151,448,000 after buying an additional 1,001,372 shares during the last quarter. Norges Bank purchased a new position in Molina Healthcare in the 4th quarter worth about $214,801,000. Durable Capital Partners LP purchased a new position in Molina Healthcare in the 1st quarter worth about $214,363,000. Invesco Ltd. increased its position in shares of Molina Healthcare by 151.6% during the 1st quarter. Invesco Ltd. now owns 893,693 shares of the company's stock valued at $298,128,000 after purchasing an additional 538,493 shares during the last quarter. Finally, State Street Corp increased its position in shares of Molina Healthcare by 25.6% during the 1st quarter. State Street Corp now owns 2,457,008 shares of the company's stock valued at $819,633,000 after purchasing an additional 501,107 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.

Molina Healthcare Price Performance

Shares of NYSE MOH traded down $0.21 during midday trading on Friday, reaching $376.57. 393,974 shares of the stock traded hands, compared to its average volume of 317,736. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.54 and a quick ratio of 1.54. The stock has a market capitalization of $22.06 billion, a PE ratio of 20.05, a P/E/G ratio of 1.06 and a beta of 0.47. Molina Healthcare, Inc. has a one year low of $266.35 and a one year high of $423.92. The company's 50 day moving average is $395.00 and its 200 day moving average is $370.18.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, February 7th. The company reported $4.38 EPS for the quarter, beating analysts' consensus estimates of $4.31 by $0.07. The firm had revenue of $9.05 billion during the quarter, compared to the consensus estimate of $8.35 billion. Molina Healthcare had a return on equity of 32.34% and a net margin of 3.20%. The company's quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the prior year, the company earned $4.10 EPS. On average, equities research analysts anticipate that Molina Healthcare, Inc. will post 23.62 earnings per share for the current year.

Insider Activity at Molina Healthcare

In related news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total transaction of $273,066.66. Following the sale, the director now owns 12,207 shares in the company, valued at approximately $4,688,220.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total transaction of $273,066.66. Following the sale, the director now owns 12,207 shares in the company, valued at approximately $4,688,220.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Mark Lowell Keim sold 15,000 shares of the stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the sale, the chief financial officer now owns 36,531 shares in the company, valued at approximately $14,121,423.36. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 16,711 shares of company stock worth $6,472,517. Company insiders own 1.10% of the company's stock.

Analyst Upgrades and Downgrades

MOH has been the subject of several research reports. UBS Group upped their price target on shares of Molina Healthcare from $350.00 to $380.00 and gave the company a "neutral" rating in a research report on Thursday, December 21st. StockNews.com lowered shares of Molina Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Thursday, February 8th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $406.00 price target on shares of Molina Healthcare in a research report on Thursday, April 4th. Truist Financial upped their price target on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a "buy" rating in a research report on Tuesday, February 20th. Finally, Bank of America downgraded Molina Healthcare from a "neutral" rating to an "underperform" rating and set a $439.00 price objective for the company. in a research note on Thursday, March 28th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $395.82.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.